1. Home
  2. NATL vs SUPN Comparison

NATL vs SUPN Comparison

Compare NATL & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATL
  • SUPN
  • Stock Information
  • Founded
  • NATL 2023
  • SUPN 2005
  • Country
  • NATL United States
  • SUPN United States
  • Employees
  • NATL N/A
  • SUPN N/A
  • Industry
  • NATL
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NATL
  • SUPN Health Care
  • Exchange
  • NATL Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • NATL 2.9B
  • SUPN 2.6B
  • IPO Year
  • NATL N/A
  • SUPN 2012
  • Fundamental
  • Price
  • NATL $40.09
  • SUPN $47.92
  • Analyst Decision
  • NATL Buy
  • SUPN Buy
  • Analyst Count
  • NATL 4
  • SUPN 2
  • Target Price
  • NATL $42.75
  • SUPN $51.50
  • AVG Volume (30 Days)
  • NATL 457.5K
  • SUPN 682.2K
  • Earning Date
  • NATL 11-11-2025
  • SUPN 11-03-2025
  • Dividend Yield
  • NATL N/A
  • SUPN N/A
  • EPS Growth
  • NATL N/A
  • SUPN 1411.53
  • EPS
  • NATL 1.71
  • SUPN 1.14
  • Revenue
  • NATL $4,271,000,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • NATL $2.73
  • SUPN $6.71
  • Revenue Next Year
  • NATL $4.51
  • SUPN $19.74
  • P/E Ratio
  • NATL $23.37
  • SUPN $42.23
  • Revenue Growth
  • NATL N/A
  • SUPN 5.55
  • 52 Week Low
  • NATL $22.30
  • SUPN $29.16
  • 52 Week High
  • NATL $40.78
  • SUPN $49.66
  • Technical
  • Relative Strength Index (RSI)
  • NATL 64.34
  • SUPN 66.02
  • Support Level
  • NATL $39.13
  • SUPN $47.34
  • Resistance Level
  • NATL $40.40
  • SUPN $49.66
  • Average True Range (ATR)
  • NATL 0.91
  • SUPN 1.23
  • MACD
  • NATL -0.15
  • SUPN -0.08
  • Stochastic Oscillator
  • NATL 87.21
  • SUPN 66.70

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: